Anti-Anxiety AgentsDiazepam Binding InhibitorToxicity TestsBenzodiazepinesFlumazenilGABA ModulatorsLorazepamReceptors, GABA-AHypnotics and SedativesToxicity Tests, AcuteBenzodiazepinonesAnticonvulsantsDose-Response Relationship, DrugChlordiazepoxideBuspironeCarbolinesMuscle Relaxants, CentralPreanesthetic MedicationMidazolamPentobarbitalSeizuresAdministration, RectalFlurazepamAlprazolamAlcohol Withdrawal DeliriumClorazepate DipotassiumDrug InteractionsDrug Administration ScheduleLethal Dose 50FlunitrazepamPentylenetetrazoleInjections, IntravenousTime FactorsAntineoplastic Combined Chemotherapy ProtocolsAdministration, OralToxicity Tests, ChronicDrug ToleranceAnesthesia, DentalMethocarbamolAntineoplastic AgentsTreatment OutcomeParaldehydeGABA-A Receptor AntagonistsInfusions, IntravenousBehavior, AnimalAnxietyPhenytoinGABA-A Receptor AgonistsSuppositoriesConvulsantsgamma-Aminobutyric AcidAdjuvants, AnesthesiaNitrazepamAnesthesia, IntravenousClonazepamMedazepamTriazolamRats, WistarAntidotesStatus EpilepticusSeizures, FebrileRats, Sprague-DawleyGABA AgonistsPhlebitisFlicker FusionMeperidineElectroshockRagePralidoxime CompoundsCisplatinTranquilizing AgentsPromethazineDrug EvaluationDouble-Blind MethodDrug SynergismMotor ActivityBarbituratesNo-Observed-Adverse-Effect LevelFluorouracilAnestheticsMeprobamateCell SurvivalMaximum Tolerated DoseSubstance Withdrawal SyndromeMuscimolChlormethiazoleMephenesinBrainClinical Trials as TopicAzabicyclo CompoundsBemegrideNeoplasmsAdministration, BuccalDigitoxinPicrotoxinDrug Evaluation, PreclinicalBenzothiepinsPremedicationSodium OxybateDoxorubicin